HealthDay

Risk higher for cardiovascular disease, diabetes, renal mortality; lower risk for cancer mortality

Five of six states with mandatory reporting receive case reports within 30 days of diagnosis

Worse survival in states with more physicians; higher death rates in states with lower incidence

Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399

Only 12.8 and 35.5 percent of fills were appropriate, potentially appropriate in outpatients

Consistent benefit observed for patients with stable ischemic heart disease managed by revascularization

In study, individual dogs’ performance varied for detecting hypoglycemic episodes, hyperglycemia

Authors say frailty should be considered in clinical care, management of Alzheimer dementia

Investigation triggered by meta-analysis showing possible increased mortality in PAD patients at 2 years

Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels

Week 4 seems better than week 8 for assessing response, implementing treatment augmentation

Link between mindfulness and symptoms more robust in women experiencing higher stress

2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016

Improvements in clinical surgery time, accuracy with use of intraoral MCS training system

Wait times similar to private sector in 2014 but shorter overall and in some specialties in 2017

No increased cancer worry for multigene panel testing versus BRCA1/2-only test after cancer diagnosis

Odds ratio for knee osteoarthritis was 0.7 in MHT group versus non-MHT group in multivariable model

Worse cognitive HRQOL and clinically meaningful impairment in school and overall HRQOL observed

Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years

Higher symptom count seen with increasing age and for women versus men